We have identified that the pathogenic alteration of SLC25A38 in a CSA patient is accompanied by significant and distinct changes in the differential expression of genes involved in essential processes of erythroid differentiation. This evidence concerns the gene SLC25A38 and chromosome-type aberration frequency.